Mark Basil Swindells
Corporate Officer/Principal en Exscientia AI Ltd. .
Perfil
Mark Basil Swindells is currently the Chief Strategy Officer at Exscientia AI Ltd.
He previously held the same position at Exscientia Plc.
Cargos activos de Mark Basil Swindells
| Empresas | Cargo | Inicio |
|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Mark Basil Swindells.
| Empresas | Cargo | Fin |
|---|---|---|
| EXSCIENTIA PLC | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Basil Swindells
